Monopar Therapeutics Inc. Announces First Patient Dosed with MNPR-101-Lu, a Novel uPAR-Targeted Therapeutic Radiopharmaceutical
Monopar Therapeutics dosed its first patient with MNPR-101-Lu, a uPAR-targeted therapeutic radiopharmaceutical for advanced cancers.Quiver AI SummaryMonopar Therapeutics Inc. has announced the first patient...
3 Momentum Stocks Soaring Into 2025 and Beyond
Given the S&P's strong performance in the last year, momentum stock plays are those that have exceeded that high bar; here are three companies with potential.
MarketBeat Week in Review – 10/21- 10/25
Equities had a mixed week, but the tech-heavy NASDAQ powered to an all-time high; big tech earnings and key economic reports could bring more volatility